SecBot SecBot
144 ·Filed Nov 6, 2026

ATRC

AtriCure, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed10d 10h ago SEC0001950047-26-010764
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The filing is a routine advance notice of a small sale by a director. The shares were acquired over five years ago via vesting, suggesting a standard portfolio rebalancing. No material read-through for the stock; monitor for any subsequent Form 4 filings to confirm execution.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$57.78
T+0 close · Nov 6, 2026 · via day close
Latest settled
−4.27%
T+5 · $55.31
Vs SPY
−2.58%
α at T+5
Next horizon
T+20
in 21d
  1. T+0 · Nov 9 $57.78entry
  2. T+1 · 7d ago −2.63%α −2.26% · $56.26
  3. T+5 · 19h ago −4.27%α −2.58% · $55.31
  4. T+20 · in 21d Pending
  5. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director B. Kristine Johnson (via her trust) filed a Form 144 notice to sell 2,452 shares of AtriCure common stock, valued at approximately $143,397. The shares were acquired through restricted stock vesting under a registered plan in 2021. The sale is small relative to the company's $3.3B market cap and represents a routine diversification move by a director.

Key Facts

  • Reporting owner: B. Kristine Johnson Declaration Trust (Director)
  • Shares to be sold: 2,452 shares of common stock
  • Estimated value: $143,397.13
  • Shares acquired on 05/20/2021 via restricted stock vesting under a registered plan
  • Proposed sale date: 11/06/2026
  • Sale represents about 0.004% of AtriCure's $3.3B market cap

Financial Impact

Sale of $143,397 worth of shares, representing approximately 0.004% of market cap

dilution (none)insider holdings

Risk Factors

  • Form 144 is an intent to sell; the sale may not be executed
  • Director sales can sometimes precede negative news, but the size here is immaterial

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
73% bullish (15 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-010764
Document: 0001950047-26-010764-index.html0001950047-26-010764
Document: 0001950047-26-010764.txt0001950047-26-010764

Track record

19 reports on ATRC

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +89.53% at T+60 after the Jun 14, 2026 report. 3 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today Institutional Cluster Mixed 3/10 Entry $55.42 Now $55.31 −0.20% settles Feb 12
  2. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $55.72 Now $55.31 −0.74% settles Feb 12
  3. Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $57.53 Now $55.31 −3.86% settles Feb 9
  4. Nov 6, 202610d ago 144 Neutral 2/10 Viewing Entry $57.78 Now $55.31 −4.27% settles Feb 5
  5. Nov 6, 202610d ago Institutional Cluster Bullish 4/10 Entry $58.54 Now $55.31 −5.52% settles Feb 4
  6. Nov 4, 202612d ago 144 Neutral 2/10 Entry $61.28 Now $55.31 −9.74% settles Feb 3
  7. Nov 3, 202613d ago 8-K Bullish 6/10 Entry $65.53 Now $55.31 −15.60% settles Feb 2
  8. Oct 30, 202617d ago SC 13G/A Neutral 2/10 Entry $61.25 Now $55.31 −9.70% settles Jan 28
  9. Oct 5, 20266w ago SC 13G/A Neutral 3/10 Entry $56.37 Now $55.31 −1.88% settles Dec 30
  10. Sep 14, 20269w ago Insider Cluster Neutral 2/10 Entry $56.22 Now $55.31 −1.62% settles Dec 9
Showing 10 of 19

US Market Status

Market Closed · Opens in 7h 3m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 6, 2026